二次旋转性心脏切除术与经过切除后长期ST段升高的发生率降低有关
Daisuke Kanda1, Takuro Takumi2, Ryo Arikawa2
1Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, Kagoshima, 890-8520, Japan. kanchan@m3.kufm.kagoshima-u.ac.jp.
Internal and emergency medicine
|August 11, 2023
概括
一个二次旋转性心脏切除术 (RA) 策略,涉及在RA之前的气球扩张,减少了长时间的ST段升高在化病变的穿皮冠状动脉干预后. 这种方法可以改善稳定性胸痛患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血管生物学 血管生物学
背景情况:
- 穿皮冠状动脉干预 (PCI) 与旋转性心脏切除术 (RA) 用于严重化的病变.
- 在PCI和缓慢流现象的解决之后,ST段的升高可能会持续下去,这表明心肌损伤的可能性.
- 影响RA后长期ST段升高的因素需要进一步调查.
研究的目的:
- 在接受选择性PCI的稳定性胸痛患者中,研究与经过RA的长时间ST段升高相关的临床因素.
- 为了比较一次性RA和二次性RA策略之间的长期ST段升高的发生率.
主要方法:
- 一项对152名患有稳定性胸痛的患者进行的研究,这些患者因严重化病变而接受选择性PCI.
- 患者被分为两组:初级RA策略 (单独RA) 和二次RA策略 (RA之前的气球扩张).
- 用单变量和多变量逻辑回归分析了临床因素和程序结果,包括长时间的ST段升高.
主要成果:
- 延长ST段升高的发生率在二次RA策略组 (3%) 与初级RA策略组 (13%),相比,在二次RA策略组显著较低.
- 低密度脂蛋白胆固醇 (LDL-C) 和甘油三的较低水平与长时间的ST段升高相反相关.
- 多变量分析证实,继发性RA策略独立地与延长ST段升高的减少发生有关,即使在调整脂质水平后也是如此.
结论:
- 一种二次RA策略,包括RA前气球扩张,似乎有效地减少RA后长期ST段升高的严重化病变的发生.
- 这一策略可能在为复杂冠状动脉疾病进行PCI的患者的管理中提供临床益处.
- 进一步的研究可以探索这一发现的潜在机制和长期影响.
相关概念视频
01:27Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
01:26Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
01:30Acute Coronary Syndrome I: Introduction
30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
20
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20